Edmund Benami - CEO, NeuraLight - Measuring Brain Health Through The Eyes

Edmund Benami is Co-Founder and CEO of NeuraLight ( https://neuralight.ai/ ), a pioneering health-tech company focused on applying advanced computer vision and deep-learning techniques to accelerate and improve drug development and patient monitoring in neurological diseases.

NeuraLight’s mission is to develop objective and sensitive biomarkers in neurology by extracting oculometric markers (measures of eye movement) from standard webcams or smartphones, thereby providing richer digital endpoints for neurological drug development and patient care.

Edmund is a repeat entrepreneur and an award-winning mathematician, with over 20 years of experience designing novel AI algorithms and building world-class teams to take on some of the most challenging technological challenges in signal processing, computer vision and AI.

Edmund has both BS and MS in Mathematics from Ben-Gurion University of the Negev.

#EdmundBenami #NeuraLight #NeurologicalDisorders #OculometricBiomarkers #Oculometry #Saccades #SmoothPursuit #Fixation #PupilDynamics #BlinkPatterns #Vergence #ALS #NeurodegenerativeDisorders #Diagnosis #DiseaseMonitoring #DrugDevelopment #ProgressiveSupranuclearPalsy #CorticobasalDegeneration #FrontotemporalDementia #LewyBodyDementia #RemoteNeurologyCare #ArtificialIntelligence #ComputerVision #Gaze #AlzheimersDisease #ParkinsonsDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research